- Home
- APRE vs KAVL Comparison
APRE vs KAVL Comparison
Compare APRE & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- KAVL
- Stock Information
- Founded
- APRE 2006
- KAVL 1998
- Country
- APRE United States
- KAVL United States
- Employees
- APRE N/A
- KAVL N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- KAVL Medicinal Chemicals and Botanical Products
- Sector
- APRE Health Care
- KAVL Health Care
- Exchange
- APRE Nasdaq
- KAVL Nasdaq
- Market Cap
- APRE 9.7M
- KAVL 7.9M
- IPO Year
- APRE 2019
- KAVL N/A
- Fundamental
- Price
- APRE $1.75
- KAVL $0.57
- Analyst Decision
- APRE Strong Buy
- KAVL
- Analyst Count
- APRE 2
- KAVL 0
- Target Price
- APRE $15.50
- KAVL N/A
- AVG Volume (30 Days)
- APRE 35.7K
- KAVL 35.5K
- Earning Date
- APRE 05-14-2025
- KAVL 06-17-2025
- Dividend Yield
- APRE N/A
- KAVL N/A
- EPS Growth
- APRE N/A
- KAVL N/A
- EPS
- APRE N/A
- KAVL N/A
- Revenue
- APRE $1,284,475.00
- KAVL $3,877,695.00
- Revenue This Year
- APRE N/A
- KAVL N/A
- Revenue Next Year
- APRE N/A
- KAVL N/A
- P/E Ratio
- APRE N/A
- KAVL N/A
- Revenue Growth
- APRE 33.27
- KAVL N/A
- 52 Week Low
- APRE $1.41
- KAVL $0.46
- 52 Week High
- APRE $5.01
- KAVL $8.37
- Technical
- Relative Strength Index (RSI)
- APRE 49.51
- KAVL 49.42
- Support Level
- APRE $1.60
- KAVL $0.54
- Resistance Level
- APRE $2.00
- KAVL $0.62
- Average True Range (ATR)
- APRE 0.16
- KAVL 0.03
- MACD
- APRE 0.02
- KAVL -0.00
- Stochastic Oscillator
- APRE 37.50
- KAVL 34.42
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.